Similar companies
Income Statement (USD)
| Q2 '24 | QoQ | |
|---|---|---|
| Revenue | 3.22B | 1.4% |
| Gross Profit | 926M | 3.2% |
| Cost of Revenue | 2.29B | 0.7% |
| Operating expense | 620M | 8.6% |
| Net Income | 205M | 10% |
| EBITDA | 377M | 6.7% |
Balance Sheet (USD)
| Q2 '24 | QoQ | |
|---|---|---|
| Total Assets | 16.7B | 1.1% |
| Total Liabilities | 8.69B | 1.6% |
| Total Equity | 8.01B | 0.6% |
| Shares Outstanding | 84M | 0.6% |
Cash Flow (USD)
| Q2 '24 | QoQ | |
|---|---|---|
| Cash from operations | 561M | 1982.9% |
| Cash from investing | -185M | 52.9% |
| Cash from financing | -210M | 1694.9% |
EPS
Financial Highlights for LabCorp in Q2 '24
LabCorp reported a revenue of 3.22B, which is a 1.4% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 926M, marking a 3.2% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 2.29B, a 0.7% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 620M, showing a 8.6% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was 205M, showing a -10% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was 377M, showing a -6.7% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
LabCorp faced some challenges this quarter with a decline in one or more of the key metrics: revenue, gross profit, or net income. Higher operating expenses might indicate increased investments or potential inefficiencies. A decline in EBITDA signals potential operational challenges or increased costs.
